Vaccines, blood, antisera, toxins and cultures in   Argentina

Exports In 2022, Argentina exported $397M in Vaccines, blood, antisera, toxins and cultures, making it the 26th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 33rd most exported product in Argentina. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Argentina are: Brazil ($157M), South Korea ($25.8M), Guatemala ($21.6M), Vietnam ($18.8M), and Colombia ($18.6M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Argentina between 2021 and 2022 were Brazil ($150M), France ($13.3M), and United States ($12.4M).

Imports In 2018, Argentina imported $1.49B in Vaccines, blood, antisera, toxins and cultures, becoming the 29th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Argentina. Argentina imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($528M), Switzerland ($252M), Belgium ($170M), Germany ($137M), and Italy ($81.3M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Argentina between 2021 and 2022 were United States ($257M), Switzerland ($39.4M), and Italy ($24M).